Evidence map›Paper›PMID 31997896›Full record

ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2019

Mzabimycins A and B, novel intracellular angucycline antibiotics produced by

Samira Tata, Adel Aouiche, Christian Bijani, Noureddine Bouras, Frédéric Pont, Florence Mathieu, Nasserdine Sabaou

Open access · hybridAbstract read
In one paragraph

Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. NewTheScientificWorldJournal · 2025
    Pooled it
  2. Molecules (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Article
  5. Rare HalophilicBioMed research international · 2023
    Article
  6. Article
  7. Diversity ofMicroorganisms · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Samira TataLaboratoire de Biologie des Systèmes Microbiens (LBSM), Ecole Normale Supérieure de Kouba, Alger, Algeria.
Adel AouicheLaboratoire de Biologie des Systèmes Microbiens (LBSM), Ecole Normale Supérieure de Kouba, Alger, Algeria.
Christian BijaniLaboratoire de Chimie de Coordination (LCC), CNRS, Université de Toulouse, UPS, INPT, LCC, 205 Route de Narbonne, 31077 Toulouse, France.
Noureddine BourasLaboratoire de Biologie des Systèmes Microbiens (LBSM), Ecole Normale Supérieure de Kouba, Alger, Algeria.
Frédéric PontProteomics Group, Centre de Recherches en Cancérologie de Toulouse (CRCT), INSERM UMR1037, Toulouse, France.
Florence MathieuLaboratoire de Génie Chimique, Université de Toulouse, CNRS, Toulouse, France.
Nasserdine SabaouLaboratoire de Biologie des Systèmes Microbiens (LBSM), Ecole Normale Supérieure de Kouba, Alger, Algeria.
École Normale Supérieure de Kouba · DZInserm · FRLaboratoire de Génie Chimique · FRUniversité Fédérale de Toulouse Midi-Pyrénées · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In our previous studies, the production of four bioactive molecules by

Indexed as

Angucycline antibioticsAntimicrobial compoundsL-TryptophanStreptomycesSynthetic medium

Identifiers

PMID31997896
PMCPMC6978613
OpenAlexW2949330551

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.